Read More

ARK’s Cathie Wood Dumps More Twitter Stock, Buys $20M in Fate Therapeutics Stock

Cathie Wood-led Ark Investment Management has bought 628,060 shares of clinical-stage biopharmaceutical company Fate Therapeutics Inc. (NASDAQ: FATE) through two of the firm’s exchange-traded funds (ETF) valued at over $20 million based on Thursday’s closing pri

ARKK

Read More

U.S. Stocks Settle Mixed, Market Volatility Increases

U.S. stocks closed mixed on Thursday, after recording sharp gains in the previous sessions. The latest data on inflation showed consumer and producer prices slowing higher-than-expected in July. However, investors realized that the Fed would still need to aggressively increase rates to fully control increasing consumer prices.

AMZN